Morgan Stanley’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Buy |
1,192,262
+34,349
| +3% | +$310K | ﹤0.01% | 3488 |
|
|
2025
Q4 | $10.4M | Buy |
1,157,913
+601,963
| +108% | +$5.69M | ﹤0.01% | 3578 |
|
|
2025
Q3 | $5.29M | Buy |
555,950
+342,862
| +161% | +$3.44M | ﹤0.01% | 4105 |
|
|
2025
Q2 | $1.88M | Buy |
213,088
+1,240
| +0.6% | +$10.1K | ﹤0.01% | 4736 |
|
|
2025
Q1 | $1.59M | Sell |
211,848
-45,375
| -18% | -$361K | ﹤0.01% | 4755 |
|
|
2024
Q4 | $2.15M | Buy |
257,223
+129,740
| +102% | +$1.11M | ﹤0.01% | 4645 |
|
|
2024
Q3 | $885K | Buy |
127,483
+64,844
| +104% | +$440K | ﹤0.01% | 5114 |
|
|
2024
Q2 | $307K | Sell |
62,639
-27,488
| -30% | -$130K | ﹤0.01% | 5497 |
|
|
2024
Q1 | $523K | Sell |
90,127
-58,159
| -39% | -$358K | ﹤0.01% | 5288 |
|
|
2023
Q4 | $971K | Buy |
148,286
+120,375
| +431% | +$563K | ﹤0.01% | 5310 |
|
|
2023
Q3 | $135K | Sell |
27,911
-23,539
| -46% | -$118K | ﹤0.01% | 5744 |
|
|
2023
Q2 | $262K | Buy |
51,450
+3,264
| +7% | +$17.6K | ﹤0.01% | 5518 |
|
|
2023
Q1 | $265K | Buy |
48,186
+37,716
| +360% | +$200K | ﹤0.01% | 5579 |
|
|
2022
Q4 | $48.1K | Sell |
10,470
-7,140
| -41% | -$36.3K | ﹤0.01% | 6306 |
|
|
2022
Q3 | $109K | Sell |
17,610
-37,964
| -68% | -$215K | ﹤0.01% | 6033 |
|
|
2022
Q2 | $248K | Buy |
55,574
+41,202
| +287% | +$188K | ﹤0.01% | 5791 |
|
|
2022
Q1 | $72K | Sell |
14,372
-2,048
| -12% | -$13K | ﹤0.01% | 6510 |
|
|
2021
Q4 | $143K | Sell |
16,420
-27,230
| -62% | -$243K | ﹤0.01% | 6246 |
|
|
2021
Q3 | $407K | Buy |
43,650
+22,416
| +106% | +$226K | ﹤0.01% | 5620 |
|
|
2021
Q2 | $272K | Buy |
21,234
+11,141
| +110% | +$120K | ﹤0.01% | 5860 |
|
|
2021
Q1 | $93K | Buy |
+10,093
| New | +$88.1K | ﹤0.01% | 6063 |
|
|
2020
Q2 | – | Sell |
-416
| Closed | -$1K | – | 6740 |
|
|
2020
Q1 | $1K | Sell |
416
-12
| -3% | -$66 | ﹤0.01% | 6499 |
|
|
2019
Q4 | $3K | Sell |
428
-719
| -63% | -$5.71K | ﹤0.01% | 6472 |
|
|
2019
Q3 | $13K | Sell |
1,147
-568
| -33% | -$10.3K | ﹤0.01% | 6137 |
|
|
2019
Q2 | $48K | Sell |
1,715
-194
| -10% | -$4.88K | ﹤0.01% | 5624 |
|
|
2019
Q1 | $51K | Sell |
1,909
-1,812
| -49% | -$66.7K | ﹤0.01% | 5654 |
|
|
2018
Q4 | $106K | Sell |
3,721
-1,471
| -28% | -$59.5K | ﹤0.01% | 5536 |
|
|
2018
Q3 | $398K | Sell |
5,192
-4,155
| -44% | -$325K | ﹤0.01% | 5123 |
|
|
2018
Q2 | $972K | Buy |
9,347
+7,163
| +328% | +$699K | ﹤0.01% | 4654 |
|
|
2018
Q1 | $276K | Buy |
2,184
+584
| +37% | +$56.5K | ﹤0.01% | 5328 |
|
|
2017
Q4 | $104K | Sell |
1,600
-284
| -15% | -$17.1K | ﹤0.01% | 5623 |
|
|
2017
Q3 | $111K | Sell |
1,884
-7
| -0.4% | -$373 | ﹤0.01% | 5545 |
|
|
2017
Q2 | $121K | Sell |
1,891
-45
| -2% | -$2.96K | ﹤0.01% | 5563 |
|
|
2017
Q1 | $151K | Buy |
1,936
+1,606
| +487% | +$97.6K | ﹤0.01% | 5443 |
|
|
2016
Q4 | $15K | Buy |
330
+93
| +39% | +$5.71K | ﹤0.01% | 6070 |
|
|
2016
Q3 | $17K | Sell |
237
-9
| -4% | -$640 | ﹤0.01% | 5963 |
|
|
2016
Q2 | $16K | Sell |
246
-544
| -69% | -$89.5K | ﹤0.01% | 5929 |
|
|
2016
Q1 | $183K | Buy |
790
+596
| +307% | +$144K | ﹤0.01% | 5028 |
|
|
2015
Q4 | $62K | Sell |
194
-46
| -19% | -$12.5K | ﹤0.01% | 5631 |
|
|
2015
Q3 | $74K | Buy |
240
+55
| +30% | +$16.8K | ﹤0.01% | 5560 |
|
|
2015
Q2 | $54K | Buy |
+185
| New | +$40.3K | ﹤0.01% | 5831 |
|
Other funds holding ZVRA
WP
NCM
VCM
ACM
